Aelis Farma
Biotech company conducting research and development on innovative signaling specific drugs.
Market cap
$14.2m
Enterprise value
$5m
Share price
€0.98 AELIS.PA
Company register number
797707627
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | €25.0m | IPO |
| Total Funding | 000k | ||
Bpifrance(exited)
Inserm Transfert Initiative(exited)
Region Nouvelle Aquitaine(exited)
Aquiti(exited)
Sofimac Innovation(exited)
Aqui-Invest(exited)
National Institute on Drug Abuse(exited)
NACo(exited)
Irdi Capital Investissement(exited)
| EUR | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | (58 %) | 138 % | (70 %) | 12 % | 276 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | 37 % | (221 %) | (51 %) | (248 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | 6 % | (375 %) | (56 %) | (278 %) | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | 76 % | 362 % | 179 % | 371 % | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.